Solventum (SOLV) FCF/Share TTM: History & Chart

Solventum Corporation(SOLV)

Medical - Instruments & Supplies · Eagan, MN

$87.65+0.00 (+0.00%)

Delayed quote: Sep 10, 2026, 4:00 PM EDT

About Solventum Corporation

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Eagan, MN

20,584 employees

www.solventum.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Bryan C. Hanson

View full financials

FCF/Share TTM

Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.

The latest quarterly fcf/share TTM is ($0.68) with QoQ Growth of +41.51%. Free cash flow per share divides trailing free cash flow by shares outstanding, showing cash generation per share.

Free Cash Flow|FCF Yield|Price/FCF Ratio|Cash Flow Statement

FCF/Share TTM

SOLV FCF/Share TTM

$-0.68

Rolling trailing-12-month free cash flow per share; no daily interpolation. Q2 FY2026 (2026-06-30): $-0.68.

-108.17% over 10Y

SOLV P/FCF Ratio

Full P/FCF Ratio page

P/FCF Ratio

SOLV P/FCF Ratio Chart

N/A

FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures Quote observation: 2026-09-10T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-02-27.

SOLV FCF Yield

Full FCF Yield page

FCF Yield

SOLV FCF Yield Chart

N/A

Four-quarter free cash flow / FMP quote market capitalization × 100 Quote observation: 2026-09-10T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-02-27.

Quarterly FCF/Share TTM History

Period	FCF/Share TTM	QoQ Growth	YoY Growth
Q2 FY2026Period end 2026-06-30	($0.68)	+41.51%	N/A
Q1 FY2026Period end 2026-03-31	($1.16)	N/A	N/A
Q4 FY2025Period end 2025-12-31	($0.06)	N/A	N/A
Q3 FY2025Period end 2025-09-30	$0.29	(66.03%)	(95.77%)
Q2 FY2025Period end 2025-06-30	$0.84	(61.91%)	(90.44%)
Q1 FY2025Period end 2025-03-31	$2.20	(52.26%)	(74.99%)
Q4 FY2024Period end 2024-12-31	$4.61	(31.55%)	(50.97%)
Q3 FY2024Period end 2024-09-30	$6.74	(23.22%)	(23.93%)
Q2 FY2024Period end 2024-06-30	$8.78	(0.32%)	(1.69%)
Q1 FY2024Period end 2024-03-31	$8.81	(6.40%)	(2.47%)
Q4 FY2023Period end 2023-12-31	$9.41	+6.20%	+13.64%
Q3 FY2023Period end 2023-09-30	$8.86	(0.78%)	N/A
Q2 FY2023Period end 2023-06-30	$8.93	(1.12%)	N/A
Q1 FY2023Period end 2023-03-31	$9.03	+9.05%	N/A
Q4 FY2022Period end 2022-12-31	$8.28	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.